Perry Daniel C, Arch Barbara, Appelbe Duncan, Francis Priya, Craven Joanna, Monsell Fergal P, Williamson Paula, Knight Marian
Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Trauma and Orthopaedics Department, Alder Hey Children's Hospital, Liverpool, UK.
Bone Joint J. 2022 Apr;104-B(4):519-528. doi: 10.1302/0301-620X.104B4.BJJ-2021-1709.R1.
The aim of this study was to inform the epidemiology and treatment of slipped capital femoral epiphysis (SCFE).
This was an anonymized comprehensive cohort study, with a nested consented cohort, following the the Idea, Development, Exploration, Assessment, Long-term study (IDEAL) framework. A total of 143 of 144 hospitals treating SCFE in Great Britain participated over an 18-month period. Patients were cross-checked against national administrative data and potential missing patients were identified. Clinician-reported outcomes were collected until two years. Patient-reported outcome measures (PROMs) were collected for a subset of participants.
A total of 486 children (513 hips) were newly affected, with a median of two patients (interquartile range 0 to 4) per hospital. The annual incidence was 3.34 (95% confidence interval (CI) 3.01 to 3.67) per 100,000 six- to 18-year-olds. Time to diagnosis in stable disease was increased in severe deformity. There was considerable variation in surgical strategy among those unable to walk at diagnosis (66 urgent surgery vs 43 surgery after interval delay), those with severe radiological deformity (34 fixation with deformity correction vs 36 without correction) and those with unaffected opposite hips (120 prophylactic fixation vs 286 no fixation). Independent risk factors for avascular necrosis (AVN) were the inability of the child to walk at presentation to hospital (adjusted odds ratio (aOR) 4.4 (95% CI 1.7 to 11.4)) and surgical technique of open reduction and internal fixation (aOR 7.5 (95% CI 2.4 to 23.2)). Overall, 33 unaffected untreated opposite hips (11.5%) were treated for SCFE by two-year follow-up. Age was the only independent risk factor for contralateral SCFE, with age under 12.5 years the optimal cut-off to define 'at risk'. Of hips treated with prophylactic fixation, none had SCFE, though complications included femoral fracture, AVN, and revision surgery. PROMs demonstrated the marked impact on quality of life on the child because of SCFE.
The experience of individual hospitals is limited and mechanisms to consolidate learning may enhance care. Diagnostic delays were common and radiological severity worsened with increasing time to diagnosis. There was unexplained variation in treatment, some of which exposes children to significant risks that should be evaluated through randomized controlled trials. Cite this article: 2022;104-B(4):519-528.
本研究旨在为股骨头骨骺滑脱(SCFE)的流行病学和治疗提供信息。
这是一项匿名的综合性队列研究,采用嵌套的同意队列,遵循构思、开发、探索、评估、长期研究(IDEAL)框架。在18个月的时间里,英国144家治疗SCFE的医院中有143家参与。将患者与国家行政数据进行交叉核对,并识别潜在的漏报患者。收集临床医生报告的结局直至两年。为一部分参与者收集患者报告的结局指标(PROMs)。
共有486名儿童(513髋)新发病,每家医院的中位数为2名患者(四分位间距为0至4)。每10万名6至18岁儿童的年发病率为3.34(95%置信区间(CI)3.01至3.67)。稳定型疾病的诊断时间在严重畸形时延长。在诊断时不能行走的患者(66例急诊手术与43例间隔延迟后手术)、有严重放射学畸形的患者(34例畸形矫正固定与36例未矫正固定)以及对侧髋关节未受累的患者(120例预防性固定与286例未固定)中,手术策略存在很大差异。股骨头缺血性坏死(AVN)的独立危险因素是患儿入院时不能行走(调整后的优势比(aOR)4.4(95%CI 1.7至11.4))以及切开复位内固定的手术技术(aOR 7.5(95%CI 2.4至23.2))。总体而言,在两年的随访中,33例未受累未治疗的对侧髋关节(11.5%)接受了SCFE治疗。年龄是对侧SCFE的唯一独立危险因素,12.5岁以下是定义“高危”的最佳临界值。在接受预防性固定治疗的髋关节中,无SCFE发生,尽管并发症包括股骨骨折、AVN和翻修手术。PROMs显示SCFE对儿童生活质量有显著影响。
各医院的经验有限,巩固学习的机制可能会改善医疗护理。诊断延迟很常见,放射学严重程度随诊断时间延长而加重。治疗存在无法解释的差异,其中一些使儿童面临重大风险,应通过随机对照试验进行评估。引用本文:2022;104 - B(4):519 - 528。